What is the catalog number for RBL2 Antibody (N-term) [APR03663G]?

The catalog number for RBL2 Antibody (N-term) [APR03663G] is APR03663G.

What sizes are available for RBL2 Antibody (N-term) [APR03663G]?

RBL2 Antibody (N-term) [APR03663G] is available in the following size(s): 50 µL, 100 µL, 200 µL, 400 µL.

How many pack sizes does RBL2 Antibody (N-term) [APR03663G] come in?

RBL2 Antibody (N-term) [APR03663G] is available in 4 different pack sizes.

Is RBL2 Antibody (N-term) [APR03663G] in stock?

RBL2 Antibody (N-term) [APR03663G] is currently made to order / not held in immediate stock. Contact us for lead time.

RBL2 Antibody (N-term) [APR03663G]

Product Specifications

Overview

We constantly strive to ensure we provide our customers with the best antibodies. As a result of this work we offer this antibody in purified format. We are in the process of updating our datasheets. If you have any questions regarding this update, please feel free to contact our technical support team. This product is a high quality RBL2 Antibody (N-term) [APR03663G].

Synonyms

Retinoblastoma-like protein 2, 130 kDa retinoblastoma-associated protein, p130, Retinoblastoma-related protein 2, RBR-2, pRb2, RBL2, RB2

Gene Name

RBL2

Gene ID

5934

UniProt

Q08999

Chromosomal Location

Nucleus.

Applications

FC, WB

Dilution

FC--1:25 WB--1:2000

Form

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.

Function

Key regulator of entry into cell division. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Probably acts as a transcription repressor by recruiting chromatin-modifying enzymes to promoters. Potent inhibitor of E2F-mediated trans-activation, associates preferentially with E2F5. Binds to cyclins A and E. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein. May act as a tumor suppressor.